Navigation Links
eNcloseII™ Anastomosis Assist Device

ProductseNcloseII™ Anastomosis Assist Device
Company CardioVations
Item eNcloseII™ Anastomosis Assist Device
Features 
Description The eNcloseII proximal anastomosis assist device was designed specifically to obviate the need for partial clamping of the aorta. The eNcloseII device can provide the surgeon with a stable, bloodless field and dramatically better hemodynamics as compared to partial occlusion clamps. An increasing number of studies have suggested that complete or partial clamping of the aorta during coronary artery revascularization procedures may play a significant role in the wide variety of near and long-term post operative complications.

  • Provides the surgeon with a stable, bloodless field.
  • Eliminates the need for partial occlusion clamping during coronary artery bypass grafting.
  • Allows the surgeon to create sutured anastomoses without modifying his standard techniques.
  • Allows for up to three anastomoses from one insertion site.
Info CardioVations
Customer Service: (800) ETHICON
Web site: http://www.cardiovations.com/

Related medicine products :

1. eNclose Anastomosis Assist Device
2. VALTRAC™ Devices (Single Use Biofragmentable Anastomosis Ring)
3. PVA, The Personal Vision Assistant
4. OME-7000 Endoscopic and Navigation Assisted Surgical Microscope
5. CardiAssist
6. TandemHeart PTVA (Percutaneous Transseptal Ventricular Assist) System
7. LionHeart Left Ventricular Assist System (LVAS)
8. Xerox Copier Assistant
9. Assistant Free™ Self-Retaining Hip Surgery Retractor System
10. Assistant Free™ Stulberg Leg Positioner
11. Assistant Free™ Knee Retractor System
Raney clip applying forceps, length 6 1/4"....
... Multifunctional instrumentation, capable of comminution, ... by means of ultra-sonic energy. ... organs, and, in particular, parenchymatous ... of tissue-selection and non-traumatic preparation ...
... Multifunctional instrumentation, capable of ... tissue by means of ultra-sonic ... on organs, and, in particular, ... advantages of tissue-selection and non-traumatic ...
... EXcel system is the recognized world ... with superior tactile feedback and exceptional ... unique surgical modality combines tissue fragmentation, ... unsurpassed performance in procedures requiring precise, ...
Medicine Products:
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” Pate ... year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 children ... those children. James saw firsthand the effect of the critical funding gap for research ...
(Date:1/19/2017)... ... January 19, 2017 , ... Connecticut Dermatology Group (CDG) ... a highly experienced and compassionate dermatologist. Dr. Kim brings an extensive background in ... “It is with considerable pleasure to welcome back Dr. Kim to the CDG team” ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... ... hosts the Atlanta Breast Surgery Symposium, a conference where hundreds of surgeons from ... in breast surgery. Covering topics from cosmetic breast augmentation to breast ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... From a ... are released almost daily linking gut health to chronic disease, mental health and general ... Year ” as an important resolution to consider. , For one Charlottesville restaurant, good ...
(Date:1/18/2017)... ... ... The V Foundation for Cancer Research, a top-rated cancer research charity, announced ... to compete in the Boston Marathon on April 17. From first-time participants to ... marathon to join Team V and support the Foundation’s mission to declare victory over ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017 The Philadelphia Pediatric Medical ... developing medical devices for children. The Consortium chose ... seed grants of $50,000 each. The devices under ... nerve signals, a hand-operated rapid blood delivery system for emergency ... babies. ...
(Date:1/18/2017)...   Regenicin, Inc. (OTC Bulletin Board: ... development and commercialization of regenerative cell therapies to restore ... the Company,s operating results for 2016 and an outline ... Company described in its recent 10-K filing with the ... The Company,s contract laboratory completed its evaluation of NovaDerm®, ...
(Date:1/18/2017)... 2017  Dermata Therapeutics, LLC, a biotechnology company ... variety of dermatological diseases, announces dosing the first ... Phase 2 acne rosacea study. DMT210 is a ... cytokines in the skin responsible for the inflammation ... This clinical trial, DMT210-003, is a 12-week, ...
Breaking Medicine Technology: